Flat Drug Utilization Trend May Continue Into 2014 Despite ACA Expansion – Express Scripts
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO George Paz cites the “teetering” economy and unemployment as reasons to expect utilization will stay flat and doesn’t anticipate the company will see a substantial sales bump from the Affordable Care Act next year.
You may also be interested in...
Rx Spending Expected To Grow 5% In First Year of Expanded Health Coverage, CMS Predicts
CMS projects the year-over-year growth in retail prescription drug spending to jump from a negative to flat growth in 2012 and 2013 to more than 5% in 2014 and nearly 7% in 2015, largely due to expanded health care coverage under the Affordable Care Act.
Managing ACA Expectations
Express Scripts CEO says prescription drug utilization will be flat in the first year of Medicaid expansion and insurance exchanges. With millions of Americans expected to get health coverage in 2014, can that projection be true?
Biopharma Sizes Up The Affordable Care Act: Buyer’s Remorse Or Winner’s Curse?
Three years into the ACA, the biopharma industry takes stock of its near-term wins and losses as the law’s critical expanded insurance coverage takes effect beginning in 2014. Pharma still isn’t sure whether the increase in covered lives from the exchanges will boost prescription sales enough to offset the rebates, taxes, and fees it agreed to pay out, or what kind of patients constitute this new market.